Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleSurvival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting.AuthorsKwok, Wang Chun; Ho, James Chung Man; Tam, Terence Chi Chun; Ip, Mary Sau Man; Lam, David Chi LeungPublicationThoracic Cancer, 2022, Vol 13, Issue 14, p2057ISSN1759-7706Publication typeArticleDOI10.1111/1759-7714.14528